LeMaitre Vascular Financials
| LMAT Stock | USD 64.03 0.20 0.31% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Debt Equity Ratio | 0.11 | 0.0641 |
|
| |||||
| Current Ratio | 4.1 | 6.3205 |
|
|
The financial analysis of LeMaitre Vascular is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for LeMaitre Vascular includes many different criteria found on its balance sheet. For example, investors should never minimize LeMaitre Vascular's ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor LeMaitre Vascular's cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in LeMaitre Vascular.
Net Income |
|
With this module, you can analyze LeMaitre financials for your investing period. You should be able to track the changes in LeMaitre Vascular individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
LeMaitre | Select Account or Indicator |
Understanding current and past LeMaitre Vascular Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of LeMaitre Vascular's financial statements are interrelated, with each one affecting the others. For example, an increase in LeMaitre Vascular's assets may result in an increase in income on the income statement.
The data published in LeMaitre Vascular's official financial statements usually reflect LeMaitre Vascular's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of LeMaitre Vascular. For example, before you start analyzing numbers published by LeMaitre accountants, it's critical to develop an understanding of what LeMaitre Vascular's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of LeMaitre Vascular's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, LeMaitre Vascular's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in LeMaitre Vascular's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of LeMaitre Vascular. Please utilize our Beneish M Score to check the likelihood of LeMaitre Vascular's management manipulating its earnings.
LeMaitre Vascular Stock Summary
LeMaitre Vascular competes with InfuSystems Holdings, Pro Dex, Utah Medical, Milestone Scientific, and Hologic. LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts. Lemaitre Vascular operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 450 people.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US5255582018 |
| CUSIP | 525558201 |
| Location | Massachusetts; U.S.A |
| Business Address | 63 Second Avenue, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | www.lemaitre.com |
| Phone | 781 221 2266 |
| Currency | USD - US Dollar |
You should never invest in LeMaitre Vascular without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of LeMaitre Stock, because this is throwing your money away. Analyzing the key information contained in LeMaitre Vascular's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
LeMaitre Vascular Key Financial Ratios
Generally speaking, LeMaitre Vascular's financial ratios allow both analysts and investors to convert raw data from LeMaitre Vascular's financial statements into concise, actionable information that can be used to evaluate the performance of LeMaitre Vascular over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that LeMaitre Vascular reports annually and quarterly.| Return On Equity | 0.11 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.21 % |
LeMaitre Vascular Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 188.3M | 252.8M | 292.8M | 310.5M | 346.8M | 364.1M | |
| Other Current Liab | 2.5M | 772K | 1.3M | 20.5M | 23.3M | 24.4M | |
| Net Debt | 3.9M | 28.0M | 2.1M | (2.5M) | (5.2M) | (5.4M) | |
| Other Current Assets | 3.3M | 2.6M | 4.2M | 6.7M | 6.4M | 3.8M | |
| Total Liab | 40.2M | 80.2M | 38.7M | 42.3M | 48.9M | 51.3M | |
| Total Current Assets | 92.1M | 94.3M | 139.9M | 161.7M | 188.9M | 198.3M | |
| Short Term Debt | 1.8M | 4.5M | 1.9M | 1.9M | 2.5M | 1.7M | |
| Cash | 11.8M | 26.8M | 13.9M | 19.1M | 24.3M | 18.3M | |
| Other Liab | 5.4M | 4.8M | 2.8M | 2.2M | 2.6M | 1.8M | |
| Retained Earnings | 57.0M | 70.6M | 88.1M | 97.8M | 115.4M | 121.2M | |
| Accounts Payable | 2.6M | 2.4M | 2.3M | 2.9M | 3.7M | 3.9M | |
| Other Assets | 1.3M | 18.4M | 2.1M | 2.7M | 3.1M | 2.3M | |
| Net Receivables | 16.6M | 19.6M | 19.6M | 22.0M | 25.1M | 13.3M | |
| Good Will | 23.8M | 29.9M | 41.7M | 65.9M | 65.9M | 69.2M | |
| Inventory | 39.5M | 45.1M | 46.1M | 50.3M | 52.3M | 54.9M | |
| Treasury Stock | (11.0M) | (11.6M) | (12.4M) | (13.0M) | (11.7M) | (11.2M) | |
| Intangible Assets | 23.2M | 58.9M | 52.7M | 46.5M | 41.7M | 43.8M | |
| Common Stock | 217K | 221K | 235K | 237K | 239K | 198.1K | |
| Net Tangible Assets | 108.2M | 113.7M | 135.5M | 155.7M | 179.1M | 188.0M | |
| Capital Surpluse | 105.9M | 114.9M | 181.6M | 189.3M | 217.7M | 111.9M |
LeMaitre Vascular Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket. The other reason investors look at the income statement is to determine what LeMaitre Vascular's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 21K | 2K | 5.9M | 1.3M | 2.2M | 986K | |
| Total Revenue | 117.2M | 129.4M | 154.4M | 161.7M | 193.5M | 203.2M | |
| Gross Profit | 79.9M | 84.6M | 101.4M | 104.9M | 121.0M | 127.0M | |
| Operating Income | 15.8M | 19.8M | 25.6M | 21.2M | 37.1M | 38.9M | |
| Ebit | 15.8M | 19.8M | 25.6M | 21.2M | 37.1M | 38.9M | |
| Research Development | 9.3M | 10.1M | 11.8M | 13.3M | 17.0M | 17.8M | |
| Ebitda | 21.2M | 28.2M | 36.6M | 30.6M | 46.6M | 48.9M | |
| Cost Of Revenue | 37.4M | 44.7M | 53.0M | 56.8M | 72.5M | 76.2M | |
| Income Before Tax | 21.7M | 27.4M | 34.3M | 27.5M | 39.5M | 41.4M | |
| Net Income | 17.9M | 21.2M | 26.9M | 20.6M | 30.1M | 31.6M | |
| Income Tax Expense | 3.7M | 6.1M | 7.4M | 6.9M | 9.4M | 9.8M | |
| Tax Provision | 3.7M | 6.1M | 7.4M | 6.9M | 8.7M | 6.3M | |
| Interest Income | 698K | 207K | 197K | 986K | 2.5M | 2.7M | |
| Net Interest Income | 698K | (1.3M) | (2.0M) | 986K | 2.5M | 2.7M |
LeMaitre Vascular Key Cash Accounts
Cash flow analysis captures how much money flows into and out of LeMaitre Vascular. It measures of how well LeMaitre is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money LeMaitre Vascular brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money LeMaitre had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what LeMaitre Vascular has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (11.3M) | (2.6M) | (5.5M) | (7.4M) | (9.8M) | (9.3M) | |
| Change In Cash | (14.5M) | 15.0M | (12.9M) | 5.3M | 5.1M | 5.4M | |
| Free Cash Flow | 10.4M | 31.8M | 30.2M | 22.1M | 29.5M | 31.0M | |
| Depreciation | 5.4M | 8.4M | 11.1M | 9.4M | 9.5M | 10.0M | |
| Other Non Cash Items | 1.2M | 1.6M | 3.5M | 4.7M | 2.3M | 2.4M | |
| Capital Expenditures | 3.8M | 3.0M | 4.9M | 3.2M | 7.3M | 7.6M | |
| Net Income | 17.9M | 21.2M | 26.9M | 20.6M | 30.1M | 31.6M | |
| End Period Cash Flow | 11.8M | 26.8M | 13.9M | 19.1M | 24.3M | 19.2M | |
| Dividends Paid | 6.7M | 7.7M | 9.3M | 11.0M | 12.4M | 13.1M | |
| Change Receivables | (1.3M) | (939K) | (818K) | (3.5M) | (3.2M) | (3.0M) | |
| Change To Netincome | 4.7M | 4.3M | 7.1M | 8.7M | 10.0M | 10.5M | |
| Investments | 901K | 20.7M | (56.2M) | (8M) | (22.9M) | (24.0M) |
LeMaitre Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining LeMaitre Vascular's current stock value. Our valuation model uses many indicators to compare LeMaitre Vascular value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across LeMaitre Vascular competition to find correlations between indicators driving LeMaitre Vascular's intrinsic value. More Info.LeMaitre Vascular is rated fifth overall in return on equity category among related companies. It is rated fourth overall in return on asset category among related companies reporting about 0.66 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for LeMaitre Vascular is roughly 1.50 . At this time, LeMaitre Vascular's Return On Equity is comparatively stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value LeMaitre Vascular by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for LeMaitre Vascular's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the LeMaitre Vascular's earnings, one of the primary drivers of an investment's value.LeMaitre Vascular Systematic Risk
LeMaitre Vascular's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. LeMaitre Vascular volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on LeMaitre Vascular correlated with the market. If Beta is less than 0 LeMaitre Vascular generally moves in the opposite direction as compared to the market. If LeMaitre Vascular Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one LeMaitre Vascular is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of LeMaitre Vascular is generally in the same direction as the market. If Beta > 1 LeMaitre Vascular moves generally in the same direction as, but more than the movement of the benchmark.
About LeMaitre Vascular Financials
What exactly are LeMaitre Vascular Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include LeMaitre Vascular's income statement, its balance sheet, and the statement of cash flows. Potential LeMaitre Vascular investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although LeMaitre Vascular investors may use each financial statement separately, they are all related. The changes in LeMaitre Vascular's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on LeMaitre Vascular's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze LeMaitre Vascular Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as LeMaitre Vascular is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of LeMaitre has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if LeMaitre Vascular's financials are consistent with your investment objective using the following steps:- Review LeMaitre Vascular's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand LeMaitre Vascular's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare LeMaitre Vascular's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if LeMaitre Vascular's stock is overvalued or undervalued.
Today, most investors in LeMaitre Vascular Stock are looking for potential investment opportunities by analyzing not only static indicators but also various LeMaitre Vascular's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of LeMaitre Vascular growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
LeMaitre Vascular April 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of LeMaitre Vascular help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of LeMaitre Vascular. We use our internally-developed statistical techniques to arrive at the intrinsic value of LeMaitre Vascular based on widely used predictive technical indicators. In general, we focus on analyzing LeMaitre Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build LeMaitre Vascular's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.75 | |||
| Information Ratio | 0.0408 | |||
| Maximum Drawdown | 18.02 | |||
| Value At Risk | (2.97) | |||
| Potential Upside | 2.83 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LeMaitre Vascular. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy LeMaitre Stock please use our How to Invest in LeMaitre Vascular guide.Note that the LeMaitre Vascular information on this page should be used as a complementary analysis to other LeMaitre Vascular's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for LeMaitre Stock analysis
When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |
Is LeMaitre Vascular's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LeMaitre Vascular. If investors know LeMaitre will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LeMaitre Vascular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.48 | Dividend Share 0.56 | Earnings Share 1.34 | Revenue Per Share 8.709 | Quarterly Revenue Growth 0.194 |
The market value of LeMaitre Vascular is measured differently than its book value, which is the value of LeMaitre that is recorded on the company's balance sheet. Investors also form their own opinion of LeMaitre Vascular's value that differs from its market value or its book value, called intrinsic value, which is LeMaitre Vascular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LeMaitre Vascular's market value can be influenced by many factors that don't directly affect LeMaitre Vascular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LeMaitre Vascular's value and its price as these two are different measures arrived at by different means. Investors typically determine if LeMaitre Vascular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LeMaitre Vascular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.